MedImmune to Present at the Bank of America 2006 Health Care Conference
Posted on: Wednesday, 10 May 2006, 15:04 CDT
GAITHERSBURG, Md., May 10 /PRNewswire-FirstCall/ -- MedImmune, Inc. announced today that it will present at the Bank of America 2006 Health Care Conference on Wednesday, May 17, 2006, at 11:40 a.m. eastern time.
The conference is being held at The Four Seasons Hotel in Las Vegas, Nev. MedImmune's presentation will be webcast live for investors at http://www.medimmune.com/ and available for replay for a period of 30 days following the conference.
About MedImmune
MedImmune strives to provide better medicines to patients, new medical options for physicians, rewarding careers to employees, and increased value to shareholders. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious diseases, cancer and inflammatory diseases. With more than 2,200 employees worldwide, MedImmune is headquartered in Maryland. For more information, visit the company's website at http://www.medimmune.com/.
This announcement may contain, in addition to historical information, certain forward-looking statements that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from those currently anticipated as a result of a number of factors, including risks and uncertainties discussed in the company's filings with the U.S. Securities and Exchange Commission. The company is developing several products for potential future marketing. There can be no assurance that such development efforts will succeed, that such products will receive required regulatory clearance or that, even if such regulatory clearance were received, such products would ultimately achieve commercial success.
MedImmune, Inc.
CONTACT: Investors: Peter Vozzo, +1-301-398-4358, or Media: Jamie Lacey,+1-301-398-4035, both of MedImmune, Inc.
Web site: http://www.medimmune.com/
Source: PRNewswire-FirstCall
Related Articles
- Research and Markets: MedImmune Inc - Product Pipeline Report
- MedImmune: A Booster Shot for Astra?
- Over 20 New Products to Launch at the Molecular Medicine Tri-Conference
- MedImmune Announces District Court's Rejection of Sun Pharmaceutical's Motion to End Litigation Regarding Generic Amifostine
- New Products to Launch at the Molecular Medicine Tri-Conference
- MedImmune Posts 3Q Loss of $64.1 Million
- MedImmune's Phase 1 Numax(TM) Study Shows Potential to Reduce RSV Disease in Upper Airway of Children
- MedImmune Amends U.S. Co-Promotion Agreement for Synagis(R) With Abbott
- VisionTree Software Helps Conference Attendees Interact and Strategize in Real-Time
- Interphase SlotOptimizer 364G Quad-Port Gigabit Ethernet AdvancedMC Mezzanine Module Unveiled at CTIA Wireless 2005 Conference; Product on Display in the PICMG Pavilion Booth #657
 |
 |
User Comments (0)
RSS Feeds